DCoH, the dimerization cofactor of the HNF-1 homeodomain proteins (hepatocyte nuclear factor-1a and b), is involved in gene expression by associating with these transcription factors. The protein also called PCD for pterin-4a-carbinolamine dehydratase is a bifunctional factor as it catalyzes also the regeneration of tetrahydrobiopterin. This coenzyme is used by the enzyme phenylalanine hydroxylase, which generates tyrosine, the precursor of catecholamines and melanin. DCoH/PCD presumably cooperates with other partners, because it is expressed earlier than HNF1 and phenylalanine hydroxylase (PAH) in early vertebrate development. It is also found in cells lacking HNF1 and PAH like skin, brain and the pigmented epithelium of the eye suggesting a yet unknown function. We show that the overexpression of DCoH/PCD in Xenopus induces the formation of ectopic pigment cells in the epidermis, that are visible earlier than the endogenous pigmentation and broader distributed. This ectopic pigmentation is accompanied by an increase in tyrosinase activity and the amount of melanin. Overexpression of DCoH/PCD induces the appearance of pigment cells also in animal cap explants, that normally differentiate into atypical epidermis. DCoH/PCD mutants with impaired carbinolamine dehydratase activity retain the potential to induce pigmentation and we propose therefore that DCoH/PCD is not simply an essential enzyme for melanin biosynthesis, but also a regulator for the differentiation of pigment producing cells. q
Introduction
The differential gene expression in embryogenesis regulated by localized transcription factors and cofactors is an essential step in forming a multicellular organism from a single cell, the egg. Often the transcriptional regulators act in protein complexes consisting of factors bound to speci®c DNA sites in promoters or enhancers together with coactivators that modulate the regulatory capacity. A well characterized example for a cofactor that enhances the transcriptional activity of a homeobox transcription factor is the interaction of DCoH/PCD (dimerization cofactor of HNF1/pterin-4a-carbinolamine dehydratase) with HNF1a and b (Mendel et al., 1991) . HNF1a and b predominantly expressed in liver, kidney, intestine and pancreas are involved in the expression of many tissue speci®c genes via binding to a speci®c DNA recognition element (for reviews see Tronche and Yaniv, 1992; Cereghini, 1996) .
The cofactor DCoH/PCD facilitates and stabilizes the dimerization of HNF1 proteins necessary for DNA binding and forms a stable heterotetrameric protein complex consisting of two HNF1 molecules and two DCoH/PCD molecules (for reviews see Kim and Burley, 1995; Suck and Ficner, 1996) . Recently, it has been shown that DCoH/PCD modulates the binding properties of HNF1a to nucleic acids, although the factor neither has any DNA and RNA af®nity (Rhee et al., 1997) nor any transcriptional activity (Mendel et al., 1991) per se.
Apparently unrelated to this regulatory role is a second function of DCoH/PCD, that was discovered concerning an enzymatic function involved in the oxidation of aromatic amino acids (Citron et al., 1992) . A homotetramer of DCoH/PCD has an enzymatic activity catalyzing the rapid regeneration of tetrahydrobiopterin (BH 4 ) after phenylalanine hydroxylase activity (for reviews see Kim and Burley, 1995; Suck and Ficner, 1996) . A mild form of hyperphenylalaninemia (HPA) (Adler et al., 1992; Citron et al., 1993; Johnen et al., 1995; Tho Èny et al., 1998a,b) and the depigmentation disorder vitiligo (Schallreuter et al., 1994) are human diseases linked to a lack or a de®ciency of DCoH/ PCD activity. The different functions of DCoH/PCD seem to be independent of one another as vitiligous patients do not suffer from HPA and vice versa. So far there is no evidence for any diminished or reduced activity of HNF1 dependent genes in the affected patients. In fact, detailed mutation analysis of DCoH/PCD affecting either HNF1 binding or the two active centres, that bind pterins, revealed that the DCoH/PCD activities do not affect each other Sourdive et al., 1997) .
The small DCoH/PCD protein of 104 amino acids is highly conserved with homologues in vertebrates, invertebrates and even in bacteria (Mendel et al., 1991; Zhao et al., 1994; Seong et al., 1998) . The bacterial DCoH/PCD homologue is involved in transcriptional regulation although no HNF1 homologues are found in prokaryotes; the DCoH/PCD activity is absolutely necessary for the expression of the bacterial PAH gene (phenylalanine hydroxylase) (Zhao et al., 1994) . A rescue of the bacterial PAH mRNA expression can be achieved by introduction of the mammalian DCoH/PCD (Endrizzi et al., 1995) suggesting an evolutionary conserved regulatory function of DCoH/PCD. Further evidence for a regulatory role in the absence of HNF1 is given by the detection of the protein in early vertebrate embryos before the HNF1 proteins are expressed (Pogge v. Pogge v. Strandmann et al., 1998) . In contrast to HNF1 (for a review see Cereghini, 1996) and the phenylalanine hydroxylase (Sanchez-Urretia et al., 1978) DCoH/ PCD is a maternal component of the vertebrate egg and prior to gastrulation it gets restricted to the cell nuclei, suggesting a function in gene regulation. DCoH/PCD is also expressed in cell types lacking HNF1, e.g. in the pigmented epithelium of the eye, in ependym cells of the brain (Pogge v. , in the skin (Lei et al., 1997) and in hair follicles (Lei and Kaufman, 1998) . Interestingly, the three dimensional structure of the DCoH/PCD homodimer possesses a concave hydrophobic surface providing a possible binding site for other macromolecules apart from HNF1 (Endrizzi et al., 1995; Ficner et al., 1995a,b) .
Results

Overexpression of DCoH/PCD induces ectopic pigmentation in Xenopus embryos
To search for a novel function of DCoH/PCD we ectopically expressed the factor in Xenopus embryos by injecting the synthetic mRNA into fertilized eggs and analyzed the phenotype of the larvae. Fig. 1A shows that overexpression of DCoH/PCD leads to the formation of ectopic pigmentation in the embryo seen as early as the late neurula (stage 20), before any pigmentation is visible in control (noninjected) embryos (Fig. 1D) . The spatial distribution of the pigment cells in DCoH/PCD injected embryos (left) and wildtype embryos (right) differs in later stages. After DCoH/PCD mRNA injection we ®nd pigmentation at stage 26 in the whole embryo (B), whereas the pigment cells of a control embryo (E) are found exclusively at the cement gland and in the head epidermis. In the swimming larvae (C,F, stage 35) the phenotypic differences of the ectopic versus endogenous pigmentation are clearly visible. The latter one is predominantly found in longitudinal stripes and in the head epidermis (F, examples are marked with arrows), and is due to the activity of dermal melanocytes which are characterized by dendrites if exposed to light (Bagnara, 1998) . In contrast pigment cells induced by overexpression of DCoH/PCD are evenly distributed all over the body and are not dendritic but punctuated (C). The overall development and the normal wildtype pigmentation seems to be delayed in the manipulated embryo (compare for example the eyes of C,F). To elucidate the ultrastructural phenotype of the induced pigment cells we performed electron microscopy of the epidermis from DCoH/PCD overexpressing embryos (stage 24, late neurula). Fig. 1G shows a typical epithelial cell of the outer epidermis with a high number of pigment granula (marked with an arrow) above the nucleus (n), which resembles to a so-called supranuclear cap (Quevedo and Holstein, 1998) . The magni®cation of the granula (Fig. 1H ) that are about 0.5 mm in diameter reveals that they are surrounded by a membrane, which is characteristic for melanin containing melanosomes.
Taken together it was shown that the overexpression of DCoH/PCD induces the formation of ectopic pigmentation, that is not found in the wildtype embryos.
The induction of ectopic pigmentation is restricted to cells of the epidermis and also found in animal cap explants
To correlate the distribution of DCoH/PCD and the areas of ectopic pigmentation we injected DCoH/PCD in only one blastomere of the two cell stage. The¯uorescence of the injected embryo (Fig. 2 , right) is due to the coinjection of the GFP (green¯uorescence protein) RNA that was used as a marker. The ectopic pigmentation is restricted to the anterior part of a stage 20 embryo ( Fig. 2A) and the left part of a stage 27 embryo (B) corresponding to the green¯uores-cence of these embryos (right). As the pigmentation is exclusively found in the parts of the embryo expressing the injected RNAs, we conclude that the mechanisms leading to the induction of pigment producing cells occur in the injected cells.
The DCoH/PCD dependent pigmentation is visible in all areas of the epidermis including the head and middle part (Fig. 1B,C ) and the tail (data not shown). To test if the pigmentation is restricted to the epidermis we removed a part of the head epidermis (Fig. 3A) revealing that the underlying mesoderm tissue is devoid of ectopic pigmentation in spite of strong GFP expression (Fig. 3B, right) .
The capacity of animal cap explants to differentiate into several cell types and tissues in response to a given factor is often used to investigate its inducing potential. The animal cap is a single layer epithelium of ectodermal origin normally differentiating into atypical epidermis. We explanted animal caps at stage 9, which derived from eggs injected with DCoH/PCD mRNA. As shown in Fig. 3 hyperpigmentation is clearly visible in single cells of DCoH/PCD overexpressing caps (C) in comparison to the control caps (D). As the animal cap evolves from the animal hemisphere of the egg, which is already pigmented, a basal level of evenly distributed pigmentation is found in control and in DCoH/PCD overexpressing caps. The ectopic pigmentation is shown after 8 h culture of the cap (Fig. 3) , but the ®rst hyperpigmented cells are already visible 1±2 h after explantation (data not shown).
Tyrosinase activity and melanin content are increased in embryos overexpressing DCoH/PCD
To investigate whether the ectopic pigmentation is correlated to an activation of a key enzyme of melanin synthesis we detected the tyrosinase (DOPA oxidase) activity, which is the rate limiting enzyme in melanin synthesis catalyzing the oxidation of tyrosine to DOPA and subsequently to melanin. For this we used the substrate L-DOPA (colourless) that is transformed into melanin (dark colour) in the presence of the functional enzyme. Fig. 4A shows embryos incubated in a l-DOPA solution. The uninjected control embryo acquires a weak staining due to melanin formation which is restricted to the areas of the endogenous pigmentation (eye and melanocytes). In contrast equally incubated embryos overexpressing DCoH/PCD are strongly stained over the whole body demonstrating the increase in tyrosinase activity. Fig. 4B shows the l-DOPA staining of embryos expressing DCoH/PCD in only one site of the body as seen by the green¯uorescence from GFP (Fig.  4C) . The increase in tyrosinase activity is restricted to the part of the embryos expressing DCoH/PCD (Fig. 4B,C) .
Measuring the amount of the pigment melanin demonstrates that the melanin content is about 50% higher in DCoH/PCD injected embryos in comparison to the untreated control embryos (Fig. 4D) . These data prove that the ectopic pigmentation in embryos induced by DCoH/ PCD is associated with ectopic tyrosinase activity and an increase in the amount of melanin.
The carbinolamine dehydratase activity of DCoH/PCD is not essential for the ectopic pigmentation
DCoH/PCD is a dual function protein with a dehydratase activity involved in the regeneration of tetrahydrobiopterin and acting as a transcriptional coactivator. It is well documented that the conserved histidine at position 63 (H63) in the DCoH/PCD sequence is part of the active centre necessary for proper enzymatic function (Koster et al., 1996; Johnen and Kaufman, 1997; Rebrin et al., 1998) , without affecting the transcriptional coactivation function (Table 1) . We injected the corresponding Xenopus DCoH-H63L mutant that has only 0.5% dehydratase activity of the wildtype to estimate the contribution of the dehydratase activity to the induction of pigmentation. As shown in a typical larvae (Fig. 5A±C ) the DCoH-H63L is as active as the wildtype protein (Fig. 1H) . In both cases nearly 90% of the injected embryos are pigmented (Table 1) . Therefore, the pterin-4a-carbinolamine dehydratase activity of DCoH/ PCD is not essential for the ectopic pigmentation. An analogues DCoH/PCD mutant with full enzymatic function but without transcriptional activity is not available, because the mutants with decreased transcriptional activity have also a reduced enzymatic activity .
Mutation of the histidine 63 in combination with histidine 62 (DCoH-H62N/H63L) practically abolishes the enzymatic activity and has a ®ve-to ten-fold reduced transcriptional activity (Table 1) . This double mutant (DCoH-H62N/ H63L) is unable to induce pigmentation (Fig. 5D±F , Table  1 ). There are only some larvae (39 of 185) with singular slightly pigmented spots that are never found in noninjected control embryos (data not shown). The inability of the double mutant H62N/H63L to induce pigmentation in Xenopus like the wildtype might be due its reduced transcriptional activity, but we found that this mutant is expressed less ef®cient than the wildtype and the H63L mutant in Xenopus (Fig. 5H) . Thus, the instability of DCoH-H62N/H63L does not allow any conclusion concerning its function in pigmentation.
Discussion
DCoH/PCD is both a cofactor of the transcription factor HNF1 and an enzyme involved in the amino acid metabolism and there is growing evidence for other functions. The high homology in structure and function of DCoH/PCD in evolu- tion (Mendel et al., 1991; Zhao et al., 1994; Seong et al., 1998) suggests that the factor provides a vital role for the organism. To investigate the function of DCoH/PCD we injected the RNA into fertilized Xenopus eggs. This leads to ectopic pigmentation of the epidermis that clearly precedes the spontaneous pigmentation and is more broadly distributed (Fig. 1) . Normally the skin pigmentation is due to the melanin synthesis of dermal melanocytes forming a functional unit with surrounding keratinocytes that receive the pigment melanin stored in melanosomes via membrane fusions (Bagnara, 1998) . The dermal melanocytes are easily detectable as they are dark and have characteristic dendrites (Bagnara, 1998) . The hyperpigmented phenotype implicates that melanin synthesis is enhanced in the DCoH/PCD injected embryos and the surplus melanin is deposited in the cells of the epidermis. Con®rming this, we ®nd an increase in melanin and enhanced tyrosinase activity, the rate limiting enzyme of melanin biosynthesis (Fig. 4) . The melanosomes, which are the transport and storage vesicles of melanin, are visible in the cells of the outer epidermis forming a supranuclear cap (Fig. 1G,H) as seen by electron microscopy. . Protein extracts derived from eggs injected with equal amounts of DCoH and both mutants each fused to a 6 £ histidine tag were analyzed in a Western blot using an anti-his antibody. co, untreated control extract; wt, DCoH/PCD wildtype; H63L, DCoH-H63L; H62N/H63L, DCoH-H62N/ H63L. Fig. 4 . Tyrosinase activity and melanin content. (A) The functional tyrosinase was detected in situ using whole embryos. The formation of dark melanin from colourless L-DOPA is visible as a dark deposition. In embryos derived from DCoH/PCD injected eggs a strong staining is seen, which is not found in untreated control embryos. (B,C) DCoH/PCD was injected in one blastomere of the two cell stage and the tyrosinase activity was detected using L-DOPA (B). The enhanced tyrosinase activity is colocalized with DCoH/PCD and the marker GFP (C) (a, anterior). (D) For each measurement of the melanin content ®ve embryos (stage 32, either untreated controls or DCoH/PCD injected larvae) were pooled. The calibration curve was run using synthetic melanin.
The delay of endogenous pigmentation in the manipulated embryos (compare Fig. 1C,F) might be due to a competition of the ectopic pigment producing cells and the normal melanocytes for the metabolites necessary for melanin synthesis.
The delay in the spontaneous pigmentation in DCoH/ PCD injected embryos is one reason that we do not anticipate that the pigment phenotype is based on an overexpression of melanin in normal melanocytes, but rather depends on ectopic differentiation of pigment producing cells. Furthermore, it is convincing that the induced pigmentation clearly precedes the endogenous melanin synthesis of control embryos (Fig. 1A,D) and occurs therefore before the normal melanocytes are differentiated. Finally in the case that normal melanocytes would be necessary for the DCoH/PCD dependent phenotype we would expect that hyperpigmentation is not inducible in animal caps. During Xenopus embryogenesis the dermal melanocytes originate from the neural crest cell population in the early neurula stages, clearly after explantation of the animal cap. Thus, the animal cap explants do not contain differentiated melanocytes or precursor neural crest cells though ectopic melanin synthesis is observed upon DCoH/PCD overexpression. These data indicate that the DCoH/PCD induced pigmentation is the result of ectopic differentiation processes, rather than an effect on the already differentiated melanocyte population. Therefore, it seems unlikely that the enzymatic activity (pterin-4a-carbinolamine dehydratase) of DCoH/ PCD is responsible for the hyperpigmentation, even though this enzyme is necessary for the proper function of the phenylalanine hydroxylase that generates tyrosine (Citron et al., 1992) , the precursor of catecholamines and melanin. Indeed, the overexpression of a DCoH/PCD mutant with a drastically reduced carbinolamine dehydratase activity (DCoH-H63L, Johnen and Kaufman, 1997) revealed that the enzymatic activity is not necessary for the induction of pigment cells (Fig. 5, Table 1 ). The induction of the pigment phenotype by the 0.5% residual activity of DCoH-H63L can be excluded: a ®ve-fold reduction of the wildtype DCoH/ PCD mRNA used for the microinjection clearly decreases the intensity of ectopic pigmentation and a ten-fold reduction did not induce ectopic pigment cells at all (data not shown). We have also shown that wildtype and DCoH-H63L mutant RNAs are translated ef®ciently resulting in nearly identical protein levels in Xenopus embryos (Fig.  5H) . Taken together we conclude that the ability of DCoH/PCD to induce pigment cells is independent of the dehydratase activity.
A potential function of DCoH/PCD for the differentiation of melanocytes has been suggested as the human depigmentation disorder vitiligo is accompanied by the absence or extremely low levels of DCoH/PCD (Schallreuter et al., 1994) . Vitiligo is characterized by the lack of differentiated melanocytes in the affected skin and the inability to synthesize melanin. Schallreuter et al. (1994) assume that the enzymatic activity of DCoH/PCD controls melanin biosynthesis in normal skin due to a competitive inhibition of the phenylalanine hydroxylase. We propose that the induction of ectopic pigmentation, which is independent of the dehydratase function, demonstrates that DCoH/PCD acts not simply as an essential enzyme for melanin biosynthesis, but also as a regulator for the differentiation of pigment producing cells.
The capacity to produce the pigment melanin responsible for skin, hair and eye colour is found in two cell types: the melanocytes and the retinal pigment cells of the eye. The origin and development of these cells clearly is different as retinal pigment cells derive from the external wall of the optic cups, whereas melanocytes originate from neural crest cells. Nevertheless, both cell types have common features, for example, the expression of melanopsin (Provencio et al., 1998) , suggesting a partially overlapping set of regulatory factors and signalling molecules necessary for differentiation (Anreiter, 1998) . Based on our results DCoH/PCD could be part of this regulatory network, because the protein is able to induce pigmentation ectopically (Figs. 1 and 2) and it is expressed endogenously in the pigmented eye epithelium as well as in skin and in hair follicles containing melanocytes (Lei et al., 1997; Lei and Kaufman, 1998; Pogge v. Strandmann et al., 1998) .
Materials and methods
Microinjection of synthetic mRNA
The Xenopus DCoH/RcCMV expression vector (Pogge v. was cut with NaeI and used as a template for in vitro transcription driven by the T7 polymerase. The GFP2 mRNA (green¯uorescence protein 2) mRNA was obtained as described inNastos et al. (1998) . The cDNA clone was kindly provided by Enrique Amaya. Approximately 250 pg DCoH/PCD mRNA and 100 pg GFP capped mRNA were injected into fertilized Xenopus embryos at the one and the two cell stage. In the late gastrula, embryos with strong¯uorescence were selected for further incubation. In vitro fertilization and culture of embryos was performed as described in Peng (1991) .
Animal cap explants
Fertilized eggs were dejellied with 2% cysteine (pH 8) for 2 mins and washed four times in 0.1 MBS (Peng, 1991) . At stage 9 the vitelline membrane of DCoH/PCD injected and non-injected embryos was removed and the animal caps (0.5 mm 2 ) were explanted. Isolated caps were immediately transferred into agarose coated 96-well plates and incubated in 1£ MBS with 50 mg/ml kanamycin at room temperature.
Tyrosinase staining and measurement of melanin content
The tyrosinase (DOPA oxidase) catalyzes the oxidation of DOPA (l-3,4-dihydroxy-phenylalanine) to melanin and the formation of a brown-black sediment is visible in the presence of the enzyme. We ®xed the embryos for 1 h at 48C in 4% formaldehyde (pH 7.4), washed with distilled water and incubated the embryos in a 0.5% solution of L-DOPA (Sigma) in 0.1 M phosphate buffer (pH 7.4) at 378C. The substrate solution was changed after 30 min and the reaction was stopped after 1 h by placing the embryos in 0.1 M phosphate buffer without l-DOPA.
For the measurement of the melanin content ®ve embryos of stage 32 were hydrolyzed in 0.2 ml 1 M NaOH overnight and the supernatant was used for the determination of the OD 414 nm in a volume of 2 ml. To calculate the melanin content a calibration curve of synthetic melanin was run.
Generation of DCoH-H63L and DCoH-H62N/H63L mutants
To create the mutants of Xenopus DCoH/PCD we used the QuickChangeSite-directed Mutagenesis Kit (Stratagene, Catalog #200518). For the H63L mutant the histidine codon CAT in position 63 was mutated to CTT coding for leucine. For the double mutant H62N/H63L also the histidine codon CAC in position 62 was mutated to AAC coding for asparagine. The template for the PCR was the DCoH/RcCMV construct used with the primer 5 H ±ggctgaaaaattagatcaccttc-cagagtggttcaatgtc for -H63L and 5
H ±ggctgaaaaattaga-taaccttccagagtggttcaatgt for -H62N/H63L. The PCR was done as recommended by the manufacture with an annealing temperature of 558C and 14 cycles. To generate the DCoH constructs with a 6-histidine tag we cloned the wildtype DCoH/PCD in the Rc-(His 6 )CMV vector and used this construct for in vitro mutagenesis. All constructs were sequenced.
To perform the Western blot entire embryos at stage 10/ 11 were homogenized as described (Nastos et al., 1998) and aliquots of 20 mg were separated on a 15% SDS gel. The gel was blotted to nitro-cellulose and histidine tagged proteins were detected as described elsewhere (Pogge v. .
